Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.